Ausgabe 6/2017
Inhalt (19 Artikel)
Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
V. Katsi, G. Georgiopoulos, A. Laina, E. Koutli, J. Parissis, C. Tsioufis, P. Nihoyannopoulos, D. Tousoulis
Effects of catheter-based renal denervation on heart failure with reduced ejection fraction: a systematic review and meta-analysis
Hidekatsu Fukuta, Toshihiko Goto, Kazuaki Wakami, Nobuyuki Ohte
Angiogenic growth factors in myocardial infarction: a critical appraisal
Hemalatha Thiagarajan, UmaMaheswari Thiyagamoorthy, Iswariya Shanmugham, Gunadharini Dharmalingam Nandagopal, Anbukkarasi Kaliyaperumal
Readmission rate after ultrafiltration in acute decompensated heart failure: a systematic review and meta-analysis
Waqas Javed Siddiqui, Andrew R. Kohut, Syed F Hasni, Jesse M. Goldman, Benjamin Silverman, Ellie Kelepouris, Howard J Eisen, Sandeep Aggarwal
Current role of echocardiography in cardiac resynchronization therapy
Donato Mele, Matteo Bertini, Michele Malagù, Marianna Nardozza, Roberto Ferrari
Effects of exercise training on anabolic and catabolic markers in patients with chronic heart failure: a systematic review
Chien-Tzu Lee, Ling-Wei Chen, Meng-Yueh Chien
Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis
Kishaan Jeyanantham, Dipak Kotecha, Devsaagar Thanki, Rebecca Dekker, Deirdre A. Lane
The MOGE(S) classification for cardiomyopathies: current status and future outlook
Julian G. Westphal, Angelos G. Rigopoulos, Constantinos Bakogiannis, Sarah E. Ludwig, Sophie Mavrogeni, Boris Bigalke, Torsten Doenst, Matthias Pauschinger, Carsten Tschöpe, P. Christian Schulze, Michel Noutsias
Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease
Vasiliki Petta, Fotis Perlikos, Stelios Loukides, Petros Bakakos, Athanasios Chalkias, Nicoletta Iacovidou, Theodoros Xanthos, Dorothea Tsekoura, Georgios Hillas
Heart failure with preserved ejection fraction: a nephrologist-directed primer
Baris Afsar, Patrick Rossignol, Loek van Heerebeek, Walter J. Paulus, Kevin Damman, Stephane Heymans, Vanessa van Empel, Alan Sag, Alan Maisel, Mehmet Kanbay
Effect of renin-angiotensin system inhibitors on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies
Hidekatsu Fukuta, Toshihiko Goto, Kazuaki Wakami, Nobuyuki Ohte
Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?
Valentine Prat, Bertrand Rozec, Chantal Gauthier, Benjamin Lauzier
Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases
Abesh Bera, Dwaipayan Sen
Protein kinase C and cardiac dysfunction: a review
Raphael M. Singh, Emanuel Cummings, Constantinos Pantos, Jaipaul Singh
Fetal programming as a predictor of adult health or disease: the need to reevaluate fetal heart function
Joana O. Miranda, Carla Ramalho, Tiago Henriques-Coelho, José Carlos Areias
Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy
Daniel J. Philipson, Eugene C. DePasquale, Eric H. Yang, Arnold S. Baas
Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease
Vaibhav B. Patel, Saumya Shah, Subodh Verma, Gavin Y. Oudit